Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorDiener, Hans Christoph
dc.contributor.authorAshina, Messoud
dc.contributor.authorDurand-Zaleski, Isabelle
dc.contributor.authorKurth, Tobias
dc.contributor.authorLantéri-Minet, Michel
dc.contributor.authorLipton, Richard B
dc.contributor.authorPozo Rosich, Patricia
dc.date.accessioned2021-06-29T11:00:46Z
dc.date.available2021-06-29T11:00:46Z
dc.date.issued2021-03
dc.identifier.citationDiener HC, Ashina M, Durand-Zaleski I, Kurth T, Lantéri-Minet M, Lipton RB, et al. Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society. Cephalalgia. 2021 Mar;41(3):279–293.
dc.identifier.issn1468-2982
dc.identifier.urihttp://hdl.handle.net/11351/6103
dc.descriptionAcute therapy; Migraine; Preventive treatment
dc.description.abstractThe Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesCephalalgia;41(3)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectTecnologia mèdica - Avaluació
dc.subjectMigranya - Prevenció
dc.subject.meshMigraine Disorders
dc.subject.mesh/prevention & control
dc.subject.meshTechnology Assessment, Biomedical
dc.titleHealth technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1177/0333102421989247
dc.subject.decstrastornos migrañosos
dc.subject.decs/prevención & control
dc.subject.decsevaluación de tecnologías biomédicas
dc.relation.publishversionhttps://journals.sagepub.com/doi/10.1177/0333102421989247
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Diener HC] Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany. [Ashina M] Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark. [Durand-Zaleski I] Université de Paris, CRESS, INSERM, INRA, URCEco, AP-HP, Hôpital de l'Hôtel Dieu, Paris, France. Santé Publique Hôpital Henri Mondor, Créteil, France. [Kurth T] Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany. [Lantéri-Minet M] Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France. [Lipton RB] Albert Einstein College of Medicine, Bronx, NY, USA. [Pozo-Rosich P] Unitat de Cefalea, Servei de Neurologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Headache Research Group, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid33472427
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record